Skip to content

PP&E (Net) at other companies

NeoGenomics logo
NeoGenomicsNEO
$83.66M-6.6%
Veracyte logo
VeracyteVCYT
$22.65M+0.5%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$30.77M-30.7%
Personalis, Inc. logo
Personalis, Inc.PSNL
$48.44M+0.9%
Guardant Health logo
Guardant HealthGH
$150.04M+16.0%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$88.59M-5.3%

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+476%
Enterprise value$279.56M+204%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s PP&E (net)?
Biodesix, Inc. (BDSX) reported PP&E (net) of $24.19M in Q1 2026.
How has Biodesix, Inc.'s PP&E (net) changed year-over-year?
Biodesix, Inc.'s PP&E (net) decreased by 10.3% year-over-year, from $26.97M to $24.19M.
What is the long-term trend for Biodesix, Inc.'s PP&E (net)?
Over 5 years (2020 to 2025), Biodesix, Inc.'s PP&E (net) has grown at a 50.8% compound annual growth rate (CAGR), from $3.18M to $24.82M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.